Travere Therapeutics Inc. (tvtx 0.5 05/15/32)
13F holders, Q2 2026 (June 30)6holders
$2.05avg. 13F price*
At the end of Q2 2026, 6 institutions reported holding Travere Therapeutics Inc. (tvtx 0.5 05/15/32) in their 13F filings. The largest holders were Loomis Sayles & Co. L P ($4.8M), State of Wisconsin Investment Board ($4.7M) and TPG GP A, LLC ($1.2M).
- Company
- Travere Therapeutics Inc. (tvtx 0.5 05/15/32)
- CUSIP
- 89422GAB3
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $11.0M |
| Exits | 0 | $0 |
Ownership 6 holders
| Loomis Sayles & Co. L P | 0.01% | New | 84,789 | $4.8M |
| State of Wisconsin Investment Board | 0.01% | New | 4,000,000 | $4.7M |
| TPG GP A, LLC | 0.03% | New | 1,000,000 | $1.2M |
| Bank of New York Mellon Corp | 0.00% | New | 250,000 | $294K |
| Cetera Investment Advisers | 0.00% | New | 21,000 | $25K |
| Choreo, LLC | 0.00% | New | 13,000 | $15K |
"% of holder's portfolio" is TRAVERE THERAPEUTICS INC (TVTX 0.5 05/15/32)'s weight in each manager's 13F, not the share of Travere Therapeutics Inc. (tvtx 0.5 05/15/32) the manager owns.